Investigation of the Real World Effectiveness of Beclomethasone Dipropionate Nasal Aerosol in Perennial Allergic Rhinitis Patients

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 02 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Beclometasone (Primary)
Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
Focus Therapeutic Use
Acronyms BALANCE
Sponsors Teva Pharmaceutical Industries

Most Recent Events

04 Nov 2015 Results presented at the 2015 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI).
14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
16 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight